800 related articles for article (PubMed ID: 30284120)
1. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
2. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
3. Deprescribing: An Application to Medication Management in Older Adults.
Bemben NM
Pharmacotherapy; 2016 Jul; 36(7):774-80. PubMed ID: 27263530
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy, the Elderly, and Deprescribing.
Jetha S
Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
[TBL] [Abstract][Full Text] [Related]
5. Drug Prescribing: Polypharmacy and Deprescribing.
McQuade BM; Campbell A
FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
[TBL] [Abstract][Full Text] [Related]
6. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
Chou J; Tong M; Brandt NJ
J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
[TBL] [Abstract][Full Text] [Related]
7. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
9. Thoughtful Prescribing and Deprescribing.
Pravodelov V
Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
[TBL] [Abstract][Full Text] [Related]
10. Impact of Potentially Inappropriate Medications on Kidney Function in Chronic Kidney Disease: Retrospective Cohort Study.
Kimura H; Yoshida S; Takeuchi M; Kawakami K
Nephron; 2023; 147(3-4):177-184. PubMed ID: 36116436
[TBL] [Abstract][Full Text] [Related]
11. Estimating the Use of Potentially Inappropriate Medications Among Older Adults in the United States.
Fralick M; Bartsch E; Ritchie CS; Sacks CA
J Am Geriatr Soc; 2020 Dec; 68(12):2927-2930. PubMed ID: 32841366
[TBL] [Abstract][Full Text] [Related]
12. Prescribing and deprescribing in chronic kidney disease.
Manski-Nankervis JA; McMorrow R; Nelson C; Jesudason S; Sluggett JK
Aust J Gen Pract; 2021 Apr; 50(4):183-187. PubMed ID: 33786539
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
Rochon PA; Petrovic M; Cherubini A; Onder G; O'Mahony D; Sternberg SA; Stall NM; Gurwitz JH
Lancet Healthy Longev; 2021 May; 2(5):e290-e300. PubMed ID: 36098136
[TBL] [Abstract][Full Text] [Related]
14. Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.
Secora A; Alexander GC; Ballew SH; Coresh J; Grams ME
Drugs Aging; 2018 Aug; 35(8):735-750. PubMed ID: 30039344
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
16. Potentially inappropriate prescribing in older adults with advanced chronic kidney disease.
Molnar AO; Bota S; Jeyakumar N; McArthur E; Battistella M; Garg AX; Sood MM; Brimble KS
PLoS One; 2020; 15(8):e0237868. PubMed ID: 32818951
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
18. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
19. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy: Evaluating Risks and Deprescribing.
Halli-Tierney AD; Scarbrough C; Carroll D
Am Fam Physician; 2019 Jul; 100(1):32-38. PubMed ID: 31259501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
